Institutional Sign In

Go

Sanofi-Aventis Czech Republic - Profitability

ROCE & ROE
Pharmaceutical | Czechia | April 2, 2020
$2.99
Excel Sheet

Sanofi-Aventis Czech Republic made a net profit of CZK 15.2 mil in 2017, down 58.8% compared to the previous year. Historically, between 2004 and 2017, the company's net profit reached a high of CZK 73.4 mil in 2005 and a low of CZK -2.02 mil in 2004.

The result implies a return on equity of 2.05% and a return on invested capital of 0.863% in 2017. That is compared to an average of 5.38% and 2.27% over the last five years.

The company has been operating with average EBITDA margin of 0.845% in the last 5 years and an average net margin of 0.534%.

Since 2012, the firm's net profit increased by -66.3% or an average of -19.5% a year.

You can see all the company’s data at Sanofi-Aventis Czech Republic profile, or you can download a report on the company in the report section.